News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2023-04-18 1:27:45 pm Jounce Acquisition: Exploring Whether It Is Worth It To Pay Up For CVR Value SeekingAlpha
2023-04-17 8:30:37 am The past five years for Jounce Therapeutics (NASDAQ:JNCE) investors has not been profitable Simply Wall St.
2023-04-11 5:57:12 am Zacks Industry Outlook Highlights Catalyst Pharmaceuticals, KalVista Pharmaceuticals, Larimar Therapeutics, Nektar Therapeutics and Jounce Therapeutics Zacks
2023-04-10 7:7:2 am 5 Stocks to Buy as the Drug Industry Rebounds in 2023 Zacks
2023-04-02 11:0:0 pm Termination of Proposed Business Combination of Jounce Therapeutics, Inc. and Redx Pharma plc GlobeNewswire
2023-03-28 9:26:4 am Jounce (JNCE) Up 21% on Accepting Concentra's Buyout Offer Zacks
2023-03-27 7:48:52 am Jounce dumps Redx Pharma for acquisition by Concentra; to cut 84% of jobs Reuters
2023-03-27 6:0:0 am Jounce Therapeutics Enters Into Agreement to Be Acquired by Concentra Biosciences for $1.85 in Cash per Share Plus Contingent Value Rights GlobeNewswire
2023-03-16 1:30:0 pm Jounce Therapeutics Announces Results from Pre-Planned Data Review of INNATE Phase 2 Trial of JTX-8064 and Pimivalimab Demonstrating Deep and Durable Responses in Platinum Resistant Ovarian Cancer GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information